Cart (0 Items)
Your cart is currently empty.
View Products
              
              
              
              
              | Size | 100ug, 1MG  | 
		
|---|---|
| Isotype | IgG4  | 
		
| Brand | ProteoGenix  | 
		
| Product type | Primary Antibodies  | 
		
| Clonality | Monoclonal Antibody  | 
		
| Expression system | Mammalian cells  | 
		
| Applications | Elisa, WB  | 
		
| Product name | Nivolumab Biosimilar - Anti-PD1 mAb - Research Grade | 
|---|---|
| Source | DrugBank DB09035 | 
| Species | Human | 
| Molecular weight | 143kDa | 
| Purity | >85% | 
| Buffer | PBS pH7.5 | 
| Delivery condition | Blue ice (+4°C) | 
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed | 
| Storage condition | 4°C for short term; -20°C for long term | 
| Brand | ProteoGenix | 
| Aliases /Synonyms | Nivolumab,Nivolumab,PD1,anti-PD1 | 
| Reference | PX-TA1004 | 
| Note | For research use only. Not suitable for clinical or therapeutic use. | 
| Isotype | IgG4 | 
| Clonality | Monoclonal Antibody | 
Nivolumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.
                Nivolumab Biosimilar - Anti-PD1 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
                Immobilized CD279 Recombinant Protein (cat. No.PX-P4117) at 0.5µg/mL (100µL/well) can bind to Nivolumab Biosimilar - Anti-PD1 mAb (cat. No.PX-TA1004) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Related products
Send us a message from the form below
Reviews
There are no reviews yet.